HENRY FOURCADE: Open Payments
NPI 1588008445 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$403 in 19 payments from 4 companies in 2025. Trend: 2023 $359 · 2024 $54 · 2025 $403
Food & beverage: $403
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $347 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: VRAYLAR, AUSTEDO XR, LYBALVI, TRINTELLIX.
Industry payments across PA — which companies pay providers there.
